Antivirals & Women
Women Respond Better Than Men to HIV Meds, Study Finds (May 3, 2007)
From aidsmap.com
FDA Public Health Advisory for Nevirapine (Viramune) (January 19, 2005)
From U.S. Food and Drug Administration
Women and HIV: The Impact of Sex/Gender on Antiretroviral Therapy and Its Complications (Summer 2003)
Kathleen Squires, M.D., speaks at the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment.
To read PDF, click here
In Bulletin of Experimental Treatments for AIDS , from San Francisco AIDS Foundation
Women Do Just as Well as Men on HAART, Major Cohort Reports (March 25, 2003)
There are subtle signs of differences, however: Women tend to switch regimens sooner, and their viral load is slightly more likely to eventually rebound, though researchers aren't yet sure why.
From aidsmap.com
Low Bone Mineral Density in HIV-Infected Women (February 14, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections , from The Body PRO
The Impact of Sex/Gender on Antiretroviral Therapy and Its Complications (February 12, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections , from The Body PRO
Viramune Affects Birth Control in HIV+ Women (March 31, 2000)
In STEP Ezine , from Seattle Treatment Education Project
Ritonavir and Menstruation (September 1999)
In Project Inform Perspective , from Project Inform
Be Aware, Not Scared! (Fall 1998)
Women and protease inhibitors.
In Women Alive Newsletter , from Women Alive
The Crix-Files (Summer 1998)
One woman's experience with Crixivan.
In Women Alive Newsletter , from Women Alive
Women and HIV: Recent Reports on Women and HIV from Worldwide Sources (April 1998)
In Bulletin of Experimental Treatments for AIDS , from San Francisco AIDS Foundation
Advertisement